Tarsus Pharmaceuticals, Inc. (TARS) vs Tango Therapeutics, Inc. (TNGX)
- Tarsus Pharmaceuticals, Inc. TARS 68.07 −4.11%
- Tango Therapeutics, Inc. TNGX 22.04 −2.91%
Tarsus Pharmaceuticals, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Tarsus Pharmaceuticals, Inc. and Tango Therapeutics, Inc. are of similar size ($3.8B and $3.5B). Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 105.2% against 48.3%. Tango Therapeutics, Inc. has the higher net margin (0.00% vs −7.67%) and the lower return on invested capital (−808.4% vs 0.00%). Across the 17 metrics below, Tarsus Pharmaceuticals, Inc. leads on 10 and Tango Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | TARS | TNGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.28% | 100.00% | 65.16% |
| Operating margin | (8.00%) | 0.00% | 0.00% |
| Net margin | (7.67%) | 0.00% | 0.00% |
| Free cash flow margin | 9.24% | 0.00% | 0.00% |
| Return on equity | (13.68%) | (21.34%) | (56.36%) |
| Return on assets | (8.40%) | (18.86%) | (48.04%) |
| Return on invested capital | 0.00% | (808.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack